Known targets — ChEMBL curated mechanism
CHRM1DRD2DRD3DRD4HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR2APDE3ASIGMAR1
The experimentally established mechanism targets of Lactic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lactic Acid SCHEMBL28569436 | 1.00 | TP53 (0.92) | — | |
| Lactic Acid SCHEMBL3776949 | 1.00 | TP53 (0.92) | — | |
| L-Lactic Acid SCHEMBL29408581 | 1.00 | TP53 (0.92) | — | |
| Lactic Acid SCHEMBL4350607 | 1.00 | TP53 (0.92) | — | |
| Lactic Acid SCHEMBL248090 | 1.00 | — | — | |
| D-Lactic Acid SCHEMBL29408597 | 1.00 | TP53 (0.92) | — | |
| L-Lactic Acid SCHEMBL5921449 | 1.00 | — | — | |
| Lactic Acid SCHEMBL2838779 | 1.00 | — | — | |
| L-Lactic Acid SCHEMBL5921377 | 1.00 | TP53 (0.92) | — | |
| Lactic Acid SCHEMBL969329 | 0.96 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102098921-A | High-loading, controlled-release magnesium oral dosage forms and methods of making and using same | WYNDEN PHARMACEUTICALS INC | 2011-06-15 | — | — | CN | claimed |
| US-20090318713-A1 | PROCESS FOR MANUFACTURING A CYCLIC DIESTER OF AN A-HYDROXY ACID | KTANTON LTD. (IL) | 2009-12-24 | — | — | US | claimed |
| US-20250381158-A1 | MAGNESIUM COMPOSITIONS AND USES THEREOF FOR NEUROLOGICAL DISORDERS | NEUROCENTRIA INC (US) | 2025-12-18 | — | — | US | disclosed |
| CN-117777478-A | Iron/titanium bimetal organic framework material and normal-temperature and normal-pressure preparation method and application thereof | 同济大学 | 2024-03-29 | — | — | CN | disclosed |
| US-20240057641-A1 | Beverages Comprising Salts with Improved Taste | THE COCA-COLA COMPANY | 2024-02-22 | — | — | US | disclosed |
| CN-113817116-B | Preparation of covalent organic framework material and application of covalent organic framework material in rare earth separation | 中国科学院兰州化学物理研究所 | 2023-03-28 | — | — | CN | disclosed |
| EP-4107215-A1 | METHODS AND SYSTEMS FOR LACTIC ACID PRODUCTION AND POLYLACTIC ACID RECYCLING | TripleW Ltd. (IL) | 2022-12-28 | — | — | EP | disclosed |
| US-11369551-B2 | Oral care compositions with improved tin compatability | THE PROCTER & GAMBLE COMPANY (US) | 2022-06-28 | — | — | US | disclosed |
| CN-109890464-B | Oral care compositions with increased whitening efficacy | 高露洁-棕榄公司 | 2022-04-05 | — | — | CN | disclosed |
| CN-113871586-A | Controllable manganese-based layered oxide electrode material and preparation method and application thereof | 武汉理工大学 | 2021-12-31 | — | — | CN | disclosed |
| CN-113143901-A | Magnesium composition and use thereof | 纽罗森特里亚股份有限公司 | 2021-07-23 | — | — | CN | disclosed |
| WO-2008116226-A2 | MAGNESIUM COMPOSITIONS AND USES THEREOF | LIU GUOSONG (US) | 2008-09-25 | — | — | WO | disclosed |
| WO-2007075255-A2 | MASTIC GUM COMPOSITION FOR USE AS A DIETARY SUPPLEMENT IN HUMANS AND ANIMALS | INTACT ENTERPRISES, INC. (US) | 2007-07-05 | — | — | WO | disclosed |
| US-20070148187-A1 | MASTIC GUM COMPOSITION FOR USE AS A DIETARY SUPPLEMENT IN HUMANS AND ANIMALS | INTACT ENTERPRISES, INC. (US) | 2007-06-28 | — | — | US | disclosed |
| US-20050220865-A1 | Compressed composition comprising magnesium salt | BLAINE PHARMACEUTICALS | 2005-10-06 | — | — | US | disclosed |
| EP-1263801-A1 | TISSUE BULKING AND COATING COMPOSITIONS | BioCure, Inc. (US) | 2002-12-11 | — | — | EP | disclosed |
| EP-1263803-A1 | EMBOLIC COMPOSITIONS | BioCure, Inc. (US) | 2002-12-11 | — | — | EP | disclosed |
| WO-2002072166-A1 | COMPOSITIONS FOR DRUG DELIVERY | BIOCURE, INC. (US) | 2002-09-19 | — | — | WO | disclosed |
| WO-2001068720-A1 | EMBOLIC COMPOSITIONS | BIOCURE, INC. (US) | 2001-09-20 | — | — | WO | disclosed |
| WO-2001068721-A1 | TISSUE BULKING AND COATING COMPOSITIONS | BIOCURE, INC. (US) | 2001-09-20 | — | — | WO | disclosed |